Dover's second quarter results were strong, driven by excellent production performance, positive margin mix from our growth platforms, and carry forward cost actions taken in prior periods. Top line performance accelerated in the quarter on broad based shipment growth in short cycle components and outperformance over secular growth exposed end markets. Order trends continued to be positive momentum in the quarter, up 7% year-over-year, bolstering our confidence in the second half outlook, with the majority of our third quarter revenue already in backlog. As an anecdote, July orders are tracking really well going into the back end of the third quarter.

We continue to invest in high ROI organic capital projects, including productivity and capacity expansion, as well as targeted footprint optimization. During the quarter, we also completed two acquisitions of attractive, fast growing assets within our high priority Pumps & Process Solutions segment. Our balance sheet strength remains an advantage that provides flexibility as we pursue value creating capital deployment to further expand our businesses in high growth, high margin areas. Underlying end market demand is healthy and is supported by our sustained order rates.

As a result, we are raising our full year adjusted EPS guidance to $9.35-$9.55, which is +14% for the full year at midpoint. Engineered Products revenue was down in the quarter on lower volumes of vehicle services. Margin performance for the segment was up on structural cost management and productivity. Clean Energy & Fueling was up 8% in the quarter, led by strong shipments in clean energy components, fluid transport, and North American retail fueling software and equipment.

What went well
  • Second quarter results were strong, driven by excellent production performance, positive margin mix from the growth platforms, and carry-forward cost actions taken in prior periods.
  • Top-line performance accelerated on broad-based shipment growth in short-cycle components and outperformance in secular-growth-exposed end markets, with orders up 7% year-over-year and the majority of Q3 revenue already in backlog.
  • Record adjusted segment EBITDA margins above 25%, supported by prior-period portfolio actions, positive growth-platform mix, and rigorous cost containment and productivity actions.
  • Adjusted EPS was up 16% in the quarter.
  • Completed two acquisitions of fast-growing assets within the high-priority Pumps & Process Solutions segment, and raised full-year adjusted EPS guidance to $9.35-$9.55 (+14% at midpoint).
  • Pumps & Process Solutions grew 4% organically on double-digit growth in single-use biopharma components, thermal connectors for data-center liquid cooling, and digital controls of midstream natural gas compression; thermal connectors grew about 50% year-to-date.
What went wrong
  • Engineered Products revenue was down on lower vehicle services volumes.
  • Climate & Sustainability Technologies revenue declined as comparative declines in food retail refrigeration cases and engineering services more than offset record CO2 systems volumes; the full-year refrigeration forecast was taken down.
  • Long-cycle polymer processing equipment was down year-over-year, and cryogenic components volume was lighter as notional backlog slid to the right on slower infrastructure build.
  • Refrigeration case (non-CO2) projects slid to the right as retail-to-consumer customers faced more pressure, contributing to a Q2 book-to-bill optically about $20 million short of one.

Guidance Changes

MetricPeriodCurrent guidance
Adjusted EPSFY2025$9.35-$9.55 (+14% at midpoint, aiming toward top of range at +16%) (raised)
Organic revenue growthFY20254%-6% (raised (1 pt FX, 1 pt acquisition, ~2 pts comps))
Free cash flow (% of revenue)FY202514-16% (unchanged)

Performance Breakdown

MetricYoYNote
Orders (consolidated bookings) +7% Continued positive momentum, up sequentially, with year-to-date book-to-bill above 1 across all five segments.
Adjusted EPS +16% Strong operational results, margin mix, and carry-forward cost actions.
Clean Energy & Fueling revenue +8% Strong shipments in clean energy components, fluid transport, and North American retail fueling software and equipment; margins up 80 bps on volume leverage, higher mix of below-ground fueling equipment, and restructuring benefit carry-forward.
Pumps & Process Solutions revenue +4% organic Double-digit growth in single-use biopharma components, thermal connectors for data-center liquid cooling, and midstream natural gas compression digital controls, plus SIKORA acquisition.
Imaging & ID stable Growth in core marking and coating partially offset by timing of textiles; margin remained at 28% adjusted EBITDA.
Thermal connectors ~+50% YTD Demand tied to liquid cooling of data centers.
Free cash flow (YTD) +$41 million (to $261M, 7% of revenue) Operating cash conversion improvements more than offset higher capital spend on growth and productivity projects.

Earnings Call Themes & Trends

TopicPrevious mentionCurrent periodTrend
Data center liquid cooling (thermal connectors, heat exchangers/SWEP)—Dover positioned as leader in connectors and co-leader in heat exchangers, adding capacity; thermal connectors up ~50% YTDRising
Restructuring and footprint optimization savings—About $30 million of savings reflected in 2025; expects at least the same in 2026 with a larger total quantum, timing split between 2026 and 2027Rising
Refrigeration / food retail demand—Full-year refrigeration forecast taken down as case business slides right, though CO2 systems at record volumes and margin upDeclining
Tariffs and price/cost$215M annualized exposure cited priorIn a positive price/cost position; no additional second-half headwind expected; reshoring on trackSteady
Biopharma single-use components—Double-digit growth but lapping Q1 restocking; growth rate expected to moderate in second half on tougher compsDeclining
M&A / capital deployment—Close to $400 million in revenue under LOI; proprietary, low-execution-risk deals; SIKORA completedRising

Q&A Summary

How did the quarter play out sequentially versus expectations, and what changed going into the back half?
First-half margin performance was slightly above expectation, helped by biopharma mix though comps are now lapping. Cryogenic components and traditional refrigeration cases were lighter. The company is ahead of where it expected to be and is simply rolling that forward; it will decide in mid-Q3 whether to maximize Q4 production or cash flow. The main change versus last quarter was removing the prior cautionary language on growth.
On second-half margins and total segment incrementals, given a strong Q2 base?
Incrementals will come down in the second half because lower-margin businesses (refrigeration, vehicle services) grow relatively faster while DPPS flattens; it is more mix-related than price or input cost, all covered in the full-year EPS guide. Management manages margin at the business/contribution level, not total EBITDA.
Can pricing at Climate & Sustainability Technologies improve, since demand is weak and price was only ~0.2%?
It is mostly an absorption/mix issue right now; the segment needs Belvac volume (not modeled for the balance of the year) and heat exchanger volumes to recover. CO2 product line mix and structural cost work are tailwinds, and the single biggest productivity project sits in this segment, leaving plenty of room to move margin up.
Was there tariff-driven pull-forward or pushouts in orders, and in which verticals?
More pushouts than pull-forward, concentrated in non-CO2 refrigeration where retail-to-consumer projects slid right, and in cryogenics/LNG where the whole infrastructure build is taking longer than expected.
On restructuring: is last year's wraparound a $30M benefit this year, with at least $30M expected next year?
Yes; about $30 million of savings are in 2025 accounts, and 2026 is expected to be at least the same with a larger total quantum. Footprint/factory projects are complex, so timing of full run-rate benefit splits between 2026 and 2027; a best estimate will be provided next quarter, visible in CapEx and cash flow.
Given the portfolio can't drive 16% EPS growth forever without M&A, what is the deal pipeline?
Management has close to $400 million in revenue under letters of intent (realistically ~$50 million of real M&A consummating within six to eight months), mostly proprietary, low-execution-risk deals rather than auctions. Capital deployment remains important and is expected to continue the steady, no-big-swings pattern of the last five years.

More on DOVER Corp

Reported 2025-07-24 · figures from the DOVER Corp Q2 2025 earnings call.

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.